Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark J Millan

Showing results (61-70 of 188) with videos related to

Pageof 19
Sort By:
European Journal of Pharmacology|April 21, 2005
The novel monoamine reuptake inhibitor and potential antidepressant, S33005, induces Arc gene expression in cerebral cortexQi Pei, Marie Sprakes, Mark J Millan, et al.
Psychopharmacology|July 12, 2002
Differential modulation of efficiency in a food-rewarded "differential reinforcement of low-rate" 72-s schedule in rats by norepinephrine and serotonin reuptake inhibitorsAnne Dekeyne, Alain Gobert, Agnès Auclair, et al.
Neuropharmacology|November 2, 2010
Differential induction of adenylyl cyclase supersensitivity by antiparkinson drugs acting as agonists at dopamine D1/D2/D3 receptors vs D2/D3 receptors only: parallel observations from co-transfected human and native cerebral receptorsGabriella Aloisi, Elena Silvano, Mario Rossi, et al.
Psychopharmacology|February 27, 2004
The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in ratsMark J Millan, Laetitia Seguin, Alain Gobert, et al.
European Journal of Pharmacology|April 17, 2004
The novel monoamine reuptake inhibitor and potential antidepressant, S33005, induces Arc gene expression in cerebral cortexQi Pei, Marie Sprakes, Mark J Millan, et al.
The Journal of Pain|November 19, 2003
Electrophysiologic characterization of the antinociceptive actions of S18616, a novel and potent alpha 2-adrenoceptor agonist, after acute and persistent pain statesRie Suzuki, G Mark Green, Mark J Millan, et al.
Pharmacology, Biochemistry, and Behavior|March 13, 2002
Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agentsMauricette Brocco, Anne Dekeyne, Sylvie Veiga, et al.
Psychopharmacology|June 29, 2005
Acute administration of the novel serotonin and noradrenaline reuptake inhibitor, S33005, markedly modifies sleep-wake cycle architecture in the ratRaymond Cespuglio, Colette Rousset, Gabriel Debilly, et al.
British Journal of Pharmacology|April 10, 2003
h5-HT(1B) receptor-mediated constitutive Galphai3-protein activation in stably transfected Chinese hamster ovary cells: an antibody capture assay reveals protean efficacy of 5-HTAdrian Newman-Tancredi, Didier Cussac, Laetitia Marini, et al.
British Journal of Pharmacology|February 7, 2018
Corticotropin-releasing factor receptor 2-deficiency eliminates social behaviour deficits and vulnerability induced by cocaineNadège Morisot, Romain Monier, Catherine Le Moine, et al.
Pageof 19

Showing results (61-70 of 188) with videos related to

Sort By:
Pageof 19
European Journal of Pharmacology|April 21, 2005
The novel monoamine reuptake inhibitor and potential antidepressant, S33005, induces Arc gene expression in cerebral cortexQi Pei, Marie Sprakes, Mark J Millan, et al.
Psychopharmacology|July 12, 2002
Differential modulation of efficiency in a food-rewarded "differential reinforcement of low-rate" 72-s schedule in rats by norepinephrine and serotonin reuptake inhibitorsAnne Dekeyne, Alain Gobert, Agnès Auclair, et al.
Neuropharmacology|November 2, 2010
Differential induction of adenylyl cyclase supersensitivity by antiparkinson drugs acting as agonists at dopamine D1/D2/D3 receptors vs D2/D3 receptors only: parallel observations from co-transfected human and native cerebral receptorsGabriella Aloisi, Elena Silvano, Mario Rossi, et al.
Psychopharmacology|February 27, 2004
The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in ratsMark J Millan, Laetitia Seguin, Alain Gobert, et al.
European Journal of Pharmacology|April 17, 2004
The novel monoamine reuptake inhibitor and potential antidepressant, S33005, induces Arc gene expression in cerebral cortexQi Pei, Marie Sprakes, Mark J Millan, et al.
The Journal of Pain|November 19, 2003
Electrophysiologic characterization of the antinociceptive actions of S18616, a novel and potent alpha 2-adrenoceptor agonist, after acute and persistent pain statesRie Suzuki, G Mark Green, Mark J Millan, et al.
Pharmacology, Biochemistry, and Behavior|March 13, 2002
Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agentsMauricette Brocco, Anne Dekeyne, Sylvie Veiga, et al.
Psychopharmacology|June 29, 2005
Acute administration of the novel serotonin and noradrenaline reuptake inhibitor, S33005, markedly modifies sleep-wake cycle architecture in the ratRaymond Cespuglio, Colette Rousset, Gabriel Debilly, et al.
British Journal of Pharmacology|April 10, 2003
h5-HT(1B) receptor-mediated constitutive Galphai3-protein activation in stably transfected Chinese hamster ovary cells: an antibody capture assay reveals protean efficacy of 5-HTAdrian Newman-Tancredi, Didier Cussac, Laetitia Marini, et al.
British Journal of Pharmacology|February 7, 2018
Corticotropin-releasing factor receptor 2-deficiency eliminates social behaviour deficits and vulnerability induced by cocaineNadège Morisot, Romain Monier, Catherine Le Moine, et al.
Pageof 19